Remove topic nih
article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

Forge Biologics joins BGTC for new AAV gene therapies development

Pharmaceutical Technology

The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations. Topic sponsors are not involved in the creation of editorial content.

FDA 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Robotic capsule could replace injected biologics

European Pharmaceutical Review

Inflammatory conditions such as ulcerative colitis have could be treated with topical medications using this innovative approach by maximising local concentration of the drug in the tissue. The research was partly funded by the National Institutes of Health (NIH) and MIT’s Department of Mechanical Engineering.

137
137
article thumbnail

Amplo Biotechnology receives NIH-NIAMS grant for gene therapy AMP-201

Pharmaceutical Technology

Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases] for its gene therapy AMP-201. Topic sponsors are not involved in the creation of editorial content.

97
article thumbnail

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

The latest development comes after GreenLight signed a partnership with the US National Institutes of Health (NIH) to develop Covid-19 vaccines against new variants. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 104
article thumbnail

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

The FDA Law Blog

These recommendations come based on the latest National Institutes for Health (NIH) and University of Massachusetts Chan Medical School study which was funded by the NIH Rapid Acceleration of Diagnostics (RADx) program. See our previous post on the topic here.)

article thumbnail

Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation

IDStewardship

Quality readings are a key element to giving them the tools to succeed and help support productive topic discussions or patient case reviews. As a junior preceptor I gave my trainees a long list of topics and instructed them on which to read each day. Others are for fun or to inspire learners to become or stay engaged.